Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Ajinomoto Launches Indian Pharma chemicals
by Jean-François Tremblay
July 25, 2011
| A version of this story appeared in
Volume 89, Issue 30
Ajinomoto OmniChem and Granules India have agreed to form a 50-50 contract manufacturing joint venture. The pair will spend up to $25 million to build a plant in the city of Vishakhapatnam, also known as Vizag, that will produce custom intermediates and active pharmaceutical ingredients. The venture will mainly target the generics market. An Ajinomoto subsidiary, Ajinomoto OmniChem is a Belgium-based producer of pharmaceutical fine chemicals. Granules produces active pharmaceutical ingredients and drugs in finished-dosage form. The venture is expected to come on-line in 2013.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter